For a better understanding of the underlying biology related to inactivation of the Hippo pathway (or activation of YAP1/TAZ) in cancer, we generated a core SOH gene expression signature by re-analyzing previously established SOH signatures from stomach, liver, ovarian, and colorectal cancers, as described in Materials and Methods (Figure 1). This evidence concerns the gene YAP1 and cancer.